Jennifer Woyach

miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib.

Guido Marcucci, Amy J. Johnson, John C. Byrd, 2014, Leukemia.